Allied Market Research
Loading...
Cart
0
New
New Allied Market Research

Digital PCR Market by Treatment Type (Droplet Digital PCR and BEAMing Digital PCR), Product Type (Digital PCR Systems, Consumables & Reagents, and Software & Services), Application (Research, Clinical Diagnostics, and Forensic & Others), and End User (Pharmaceuticals & Biotechnology Industries, Clinical Diagnostic Laboratories, and Universities & Other Organizations): Opportunity Analysis and Industry Forecast, 2020–2027

A00532
Pages: 237
Nov 2020 | 8246 Views
 
Author(s) : Sanjivan Gill, Sahil Sinha
Tables: 143
Charts: 39
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Pcr Market

Request Now !

The global digital polymerase chain reaction market generated $398 million in 2019, and is projected to reach $1,052 million by 2027, growing at a CAGR of 12.3% from 2020 to 2027.

Droplet digital PCR (ddPCR) segment is expected to witness growth. This is due to surge in use of ddPCR technology and launch of new ddPCR assay for the detection of COVID-19.

Digital polymerase chain reaction (dPCR) is a new approach for detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in the research (basic research and applied research), clinical diagnostics, forensics, and others similar arenas. dPCR systems are useful in determination of copy number variation (CNV), rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.

Digtial-PCR--Market-2020-2027

Get more information on this report : Request Sample Pages

The global digital polymerase chain reaction market is expected to register substantial growth in the near future, owing to rise in prevalence of infectious diseases and surge in awareness & acceptance of personalized medicines. In addition, advancements in the technique are expected to boost the digital PCR market growth during the forecast period. However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities is expected to offer remunerative opportunities for dPCR market players.

The unprecedented nature of the COVID-19 pandemic and its impact on the global economy has disrupted various businesses, which, in turn, hampered the demand for certain products for medical and industrial applications as well as increased variability in its supply chain and manufacturing productivity. However, owing to the global pandemic, the necessity of a highly sensitive molecular diagnosis to considerably reduce false negatives reverse transcription PCR (rtPCR) results raised as a major clinical need for a robust diagnostic tool for the detection of COVID-19. Since the COVID-19 pandemic, significant researches have been published in favor of dPCR over quantitative polymerase chain reaction (qPCR) for COVID-19 testing. Furthermore, notable rise has been in the demand for ddPCR systems and SARS-CoV-2 kits, owing to various factors such as higher sensitivity of ddPCR, lack of inhibition from sample types, and ease in understanding the results. Moreover, owing to the imperative requirement of the diagnostic tests for the COVID-19, several key players acquired the U.S. Food and Drug Administration (FDA) Emergency Use Authorization for their dPCR test kits to meet the demand. Therefore, COVID-19 had a positive impact on the global dPCR market.

Global Digital Pcr Market Segmentation  

The report segments the global digital PCR market into technology, product type, application, end user, and region. Depending technology, the market is categorized into droplet digital PCR (ddPCR) and BEAMing digital PCR. On the basis of product type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The applications covered in the study include research, clinical diagnostics, and forensic & others. On the basis of end user, the market is fragmented into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review

On the basis of technology, the ddPCR segment was the major revenue contributor in 2019, owing to the fact that ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, massive sample partitioning is a key aspect of the ddPCR technique that allows reliable detection in samples, thereby increasing the demand. 

Digital PCR Market
By Technology

Your browser does not support the canvas element.

Droplet Digital PCR segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of product type, the software & services segment is projected to exhibit the fastest growth during the forecast period, as the software helps to improve the efficiency of management of dPCR data. Thus, the demand for these products increases, thereby propelling the digital polymerase chain reaction market growth. 

By application, the clinical diagnostics segment generated the highest revenue in 2019, and is anticipated to maintain its dominance throughout the forecast period. This is attributed to rise in incidence of infectious diseases and increase in number of cancer patients across the globe. The market for clinical diagnostics is experiencing continuous growth, due to the emergence of molecular diagnostics and disease-specific treatments, which are introduced to patients at many hospitals and clinics throughout the world. 

Digital PCR Market
By Application

Your browser does not support the canvas element.

Forensics and others segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

On the basis of end user, the clinical diagnostic laboratories generated the highest revenue in 2019, and is anticipated to continue this trend in the near future. This is attributed to surge in adoption of the dPCR in clinical diagnostic laboratories. However, the universities & other organizations segment is expected to witness highest growth, owing to increase in spending on R&D in the field of biotechnology. 

In 2019, North America was the leading revenue contributor to the global digital polymerase chain reaction market, and is expected to remain dominant throughout the forecast period. This is attributed to its well-developed healthcare industry, presence of leading molecular diagnostics manufacturers in the region, and rise in number of patients using personalized medicines. However, Asia-Pacific is expected to grow at the highest CAGR of 14.8% during forecast period, as it offers lucrative opportunities for molecular diagnostics players, due to increase in number of patients suffering from chronic diseases and improvement in healthcare facilities in the region.

Digital PCR Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 14.8% during 2020-2027.

Get more information on this report : Request Sample Pages

The global digital PCR market is highly competitive, and prominent players have adopted various strategies to garner maximum share. Major players operating in the market include 4basebio AG, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Combinati, Inc., JN Medsys, Merck KGaA, Qiagen N.V., Stilla Technologies, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Key Benefits For Stakeholders

  • This report highlights the market dynamics to understand the global digital polymerase chain reaction market and capitalize on the prevailing opportunities.
  • Quantitative analysis of the current trends and future estimations assist stakeholders to design business strategies accordingly. 
  • Porter’s five forces analysis examines the competitive market structure and provides a deeper understanding of the influencing factors for entry and expansion.
  • Pin-point analysis of geographical segments offers identification of most profitable segments to capitalize on.

Key Market Segments

By Technology Type

  • Droplet Digital PCR
  • BEAMing Digital PCR

By Product Type

  • Digital PCR Systems
  • Consumables & Reagents
  • Software & Services

By Application

  • Research
  • Clinical Diagnostics
  • Forensic & Others

By End User

  • Pharmaceuticals & Biotechnology Industries
  • Clinical Diagnostic Laboratories
  • Universities & Other Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in prevalence of infectious diseases and cancer
3.5.1.2.Increase in awareness and acceptance of personalized medicines
3.5.1.3.Technological advancements

3.5.2.Restraints

3.5.2.1.High cost of dPCR devices
3.5.2.2.Reimbursement issues

3.5.3.Opportunity

3.5.3.1.Increase in funding for R&D activities

3.6.Impact analysis of COVID-19 on the digital PCR market

CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Droplet digital PCR

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.BEAMing dPCR

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Consumables & reagents

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Digital PCR systems

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Software & services

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Research

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Clinical diagnostics

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Forensic & others

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Clinical diagnostic laboratories

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Pharmaceuticals & biotechnology industries

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

7.4.Universities & other organizations

7.4.1.Market size and forecast
7.4.2.Market analysis, by country

CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION

8.1.OVERVIEW

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.North America digital PCR market, by country

8.2.2.1.U.S. digital PCR market, by technology
8.2.2.2.U.S. digital PCR market, by product type
8.2.2.3.U.S. digital PCR market, by application
8.2.2.4.U.S. digital PCR market, by end user
8.2.2.5.Canada digital PCR market, by technology
8.2.2.6.Canada digital PCR market, by product type
8.2.2.7.Canada digital PCR market, by application
8.2.2.8.Canada digital PCR market, by end user
8.2.2.9.Mexico digital PCR market, by technology
8.2.2.10.Mexico digital PCR market, by product type
8.2.2.11.Mexico digital PCR market, by application
8.2.2.12.Mexico digital PCR market, by end user

8.2.3.North America digital PCR market, by technology
8.2.4.North America digital PCR market, by product type
8.2.5.North America digital PCR market, by application
8.2.6.North America digital PCR market, by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Europe digital PCR market, by country

8.3.2.1.Germany digital PCR market, by technology
8.3.2.2.Germany digital PCR market, by product type
8.3.2.3.Germany digital PCR market, by application
8.3.2.4.Germany digital PCR market, by end user
8.3.2.5.France digital PCR market, by technology
8.3.2.6.France digital PCR market, by product type
8.3.2.7.France digital PCR market, by application
8.3.2.8.France digital PCR market, by end user
8.3.2.9.UK digital PCR market, by technology
8.3.2.10.UK digital PCR market, by product type
8.3.2.11.UK digital PCR market, by application
8.3.2.12.UK digital PCR market, by end user
8.3.2.13.Italy digital PCR market, by technology
8.3.2.14.Italy digital PCR market, by product type
8.3.2.15.Italy digital PCR market, by application
8.3.2.16.Italy digital PCR market, by end user
8.3.2.17.Spain digital PCR market, by technology
8.3.2.18.Spain digital PCR market, by product type
8.3.2.19.Spain digital PCR market, by application
8.3.2.20.Spain digital PCR market, by end user
8.3.2.21.Rest of Europe digital PCR market, by technology
8.3.2.22.Rest of Europe digital PCR market, by product type
8.3.2.23.Rest of Europe digital PCR market, by application
8.3.2.24.Rest of Europe digital PCR market, by end user

8.3.3.Europe digital PCR market, by technology
8.3.4.Europe digital PCR market, by product type
8.3.5.Europe digital PCR market, by application
8.3.6.Europe digital PCR market, by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific digital PCR market, by country

8.4.2.1.Japan digital PCR market, by technology
8.4.2.2.Japan digital PCR market, by product type
8.4.2.3.Japan digital PCR market, by application
8.4.2.4.Japan digital PCR market, by end user
8.4.2.5.China digital PCR market, by technology
8.4.2.6.China digital PCR market, by product type
8.4.2.7.China digital PCR market, by application
8.4.2.8.China digital PCR market, by end user
8.4.2.9.Australia digital PCR market, by technology
8.4.2.10.Australia digital PCR market, by product type
8.4.2.11.Australia digital PCR market, by application
8.4.2.12.Australia digital PCR market, by end user
8.4.2.13.India digital PCR market, by technology
8.4.2.14.India digital PCR market, by product type
8.4.2.15.India digital PCR market, by application
8.4.2.16.India digital PCR market, by end user
8.4.2.17.South Korea digital PCR market, by technology
8.4.2.18.South Korea digital PCR market, by product type
8.4.2.19.South Korea digital PCR market, by application
8.4.2.20.South Korea digital PCR market, by end user
8.4.2.21.Taiwan digital PCR market, by technology
8.4.2.22.Taiwan digital PCR market, by product type
8.4.2.23.Taiwan digital PCR market, by application
8.4.2.24.Taiwan digital PCR market, by end user
8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user

8.4.3.Asia-Pacific digital PCR market, by technology
8.4.4.Asia-Pacific digital PCR market, by product type

8.4.5.Asia-Pacific digital PCR market, by application
8.4.6.Asia-Pacific digital PCR market, by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.LAMEA digital PCR market, by country

8.5.2.1.Brazil digital PCR market, by technology
8.5.2.2.Brazil digital PCR market, by product type
8.5.2.3.Brazil digital PCR market, by application
8.5.2.4.Brazil digital PCR market, by end user
8.5.2.5.Saudi Arabia digital PCR market, by technology
8.5.2.6.Saudi Arabia digital PCR market, by product type
8.5.2.7.Saudi Arabia digital PCR market, by application
8.5.2.8.Saudi Arabia digital PCR market, by end user
8.5.2.9.South Africa digital PCR market, by technology
8.5.2.10.South Africa digital PCR market, by product type
8.5.2.11.South Africa digital PCR market, by application
8.5.2.12.South Africa digital PCR market, by end user
8.5.2.13.Rest of LAMEA digital PCR market, by technology
8.5.2.14.Rest of LAMEA digital PCR market, by product type
8.5.2.15.Rest of LAMEA digital PCR market, by application
8.5.2.16.Rest of LAMEA digital PCR market, by end user

8.5.3.LAMEA digital PCR market, by technology
8.5.4.LAMEA digital PCR market, by product type
8.5.5.LAMEA digital PCR market, by application
8.5.6.LAMEA digital PCR market, by end user

CHAPTER 9:COMPANY PROFILES

9.1.BIO-RAD LABORATORIES, INC.

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.4BASEBIO AG

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business Performance

9.3.COMBINATI, INC.

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.FLUIDIGM CORPORATION

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance

9.5.JN MEDSYS

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.MERCK KGAA

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.QIAGEN N.V.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segment
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.SYSMEX CORPORATION

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance

9.9.STILLA TECHNOLOGIES

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.THERMO FISHER SCIENTIFIC, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance

LIST OF TABLES

TABLE 01.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY, 2019–2027 ($MILLION)
TABLE 02.DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.BEAMING PCR MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 05.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 06.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY REGION, 2019–2027 ($MILLION)
TABLE 07.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH, BY REGION, 2019–2027 ($MILLION)
TABLE 10.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 11.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 13.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 14.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2019–2027 ($MILLION)
TABLE 15.DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 16.DIGITAL PCR MARKET REVENUE, BY REGION, 2019–2027($MILLION)
TABLE 17.NORTH AMERICA DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 18.U.S. DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 19.U.S. DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 20.U.S. DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 21.U.S. DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 22.CANADA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 23.CANADA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 24.CANADA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 25.CANADA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 26.MEXICO DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 27.MEXICO DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 28.MEXICO DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 29.MEXICO DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 30.NORTH AMERICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 31.NORTH AMERICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 32.NORTH AMERICA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 33.NORTH AMERICA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 34.EUROPE DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 35.GERMANY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 36.GERMANY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 37.GERMANY DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 38.GERMANY DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 39.FRANCE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 40.FRANCE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 41.FRANCE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 42.FRANCE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 43.UK DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 44.UK DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 45.UK DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 46.UK DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 47.ITALY DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 48.ITALY DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 49.ITALY DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 50.ITALY DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 51.SPAIN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 52.SPAIN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 53.SPAIN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 54.SPAIN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 55.REST OF EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 56.REST OF EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 57.REST OF EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 58.REST OF EUROPE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 59.EUROPE DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 60.EUROPE DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 61.EUROPE DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 62.EUROPE DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.ASIA-PACIFIC DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 64.JAPAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 65.JAPAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 66.JAPAN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 67.JAPAN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 68.CHINA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 69.CHINA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 70.CHINA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 71.CHINA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.AUSTRALIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 73.AUSTRALIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 74.AUSTRALIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 75.AUSTRALIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.INDIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 77.INDIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 78.INDIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 79.INDIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 80.SOUTH KOREA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 81.SOUTH KOREA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 82.SOUTH KOREA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 83.SOUTH KOREA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 84.TAIWAN DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 85.TAIWAN DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 86.TAIWAN DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 87.TAIWAN DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 88.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 89.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 90.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 91.REST OF ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 92.ASIA-PACIFIC DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 93.ASIA-PACIFIC DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 94.ASIA-PACIFIC DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 95.ASIA-PACIFIC DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 96.LAMEA DIGITAL PCR MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 97.BRAZIL DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 98.BRAZIL DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 99.BRAZIL DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 100.BRAZIL DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 101.SAUDI ARABIA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 102.SAUDI ARABIA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 103.SAUDI ARABIA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 104.SAUDI ARABIA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 105.SOUTH AFRICA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 106.SOUTH AFRICA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 107.SOUTH AFRICA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 108.SOUTH AFRICA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 109.REST OF LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 110.REST OF LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 111.REST OF LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 112.REST OF LAMEA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 113.LAMEA DIGITAL PCR MARKET, BY TECHNOLOGY, 2019–2027($MILLION)
TABLE 114.LAMEA DIGITAL PCR MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 115.LAMEA DIGITAL PCR MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 116.LAMEA DIGITAL PCR MARKET, BY END USER, 2019–2027($MILLION)
TABLE 117.BIO-RAD: COMPANY SNAPSHOT
TABLE 118.BIO-RAD: OERATING SEGMENT
TABLE 119.BIO-RAD: PRODUCT PORTFOLIO
TABLE 120.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121.4BASEBIO: COMPANY SNAPSHOT
TABLE 122.4BASEBIO: PRODUCT PORTFOLIO
TABLE 123.COMBINATI: COMPANY SNAPSHOT
TABLE 124.COMBINATI: PRODUCT PORTFOLIO
TABLE 125.COMBINATI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126.FLUIDIGM: COMPANY SNAPSHOT
TABLE 127.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 128.JN MEDSYS: COMPANY SNAPSHOT
TABLE 129.JN MEDSYS: PRODUCT PORTFOLIO
TABLE 130.MERCK: COMPANY SNAPSHOT
TABLE 131.MERCK: OPERATING SEGMENTS
TABLE 132.MERCK: PRODUCT PORTFOLIO
TABLE 133.QIAGEN: COMPANY SNAPSHOT
TABLE 134.QIAGEN: PRODUCT SEGMENT
TABLE 135.QIAGEN: PRODUCT PORTFOLIO
TABLE 136.SYSMEX: COMPANY SNAPSHOT
TABLE 137.SYSMEX: OERATING SEGMENT
TABLE 138.SYSMEX.: PRODUCT PORTFOLIO
TABLE 139.STILLA: COMPANY SNAPSHOT
TABLE 140.STILLA: PRODUCT PORTFOLIO
TABLE 141.THERMO FISHER: COMPANY SNAPSHOT
TABLE 142.THERMO FISHER.: OERATING SEGMENT
TABLE 143.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION OF GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET
FIGURE 02.TOP INVESTMENT POCKETS, 2019
FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.HIGH THREAT OF SUBSTITUTION
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: TOP PLAYER POSITIONING, 2019
FIGURE 09.GLOBAL DIGITAL POLYMERASE CHAIN REACTION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DROPLET DIGITAL POLYMERASE CHAIN REACTION MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF BEAMING PCR MARKET, BY COUNTRY, 2019 & 2027 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR DIGITAL PCR SYSTEMS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR SOFTWARE & SERVICE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR RESEARCH,  BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR FORENSIC & OTHERS,  BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DIGITAL POLYMERASE CHAIN REACTION MARKET FOR UNIVERSITIES & OTHER ORGANIZATIONS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 22.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 23.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 24.4BASEBIO: NET SALES, 2017–2019 ($MILLION)
FIGURE 25.FLUIDIGM: NET SALES, 2017-2019 ($MILLION)
FIGURE 26.FLUIDIGM: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 27.FLUIDIGM: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 28.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 29.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 30.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 31.QIAGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.QIAGEN: REVENUE SHARE, BY PRODUCT, 2019 (%)
FIGURE 33.QIAGEN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 34.SYSMEX: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.SYSMEX: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 36.SYSMEX: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 37.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 39.THERMO FISHER: REVENUE SHARE BY REGION, 2019 (%)

 
 

According to the analyst, the utilization of dPCR is anticipated to witness a significant rise with technological advancements, rise in prevalence of infectious diseases, outbreak of COVID-19 pandemic, and increase in awareness & acceptance of personalized medicines.

The CXOs further added that increase in economic strength of the developing nations, such as Japan, China, India, Indonesia, and Thailand, as well as rise in healthcare expenditure are expected to drive the market growth during the forecast period. 

Rapid surge was observed in the adoption of technologically advanced medical devices across developing economies, which is expected to offset the challenging conditions in mature markets, such as North America and Europe. Moreover, North America and Europe are expected to dominate during the forecast period, while emerging countries in Asia-Pacific and Latin America are expected to offer potential growth opportunities.
 

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. Top companies such as,Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Merck KGaA, Stilla Technologies, and JN Medsys held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Droplet digital PCR segment is the most influencing segment owing to high adoption of the technology.

A. The major factor that fuels the growth of the rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. In addition, advancements in the technique is expected to boost the market growth during the forecast period.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 17.10% and India with a CAGR of 16.40%. This is due to improvement in healthcare infrastructure, and rise in number of hospitals & diagnostic centers equipped with advanced medical facilities.

A. The total market value of digtial PCR market is $397.5 million in 2019.

A. The forcast period for digtial PCR market is 2020 to 2027

A. The market value of digtial PCR market in 2020 is anticipated to be $465.9 million.

A. The base year is 2019 in digtial PCR market

A. Digital PCR is a relatively new approach for detection and quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample.

A. The dPCR is used in research (basic research and applied research), clinical diagnostics, forensics, and others similar arenas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Digital PCR Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts